Potential structural efficiency of Chinese commercial banks
Journal of Business Economics and Management · 20.03.2026 · 27 (2) · 243-261
DOI: 10.3846/jbem.2026.25750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Business Economics and Management, online erschienen am 20.03.2026. Verfasst von Zhiqian Yu und 4 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Given that structural efficiency serves as a significant instrument, this paper applies a novel approach to measure structural efficiency levels within Chinese banks from the perspective of potential improvement. To further investigate the patterns of structural efficiency, the overall structural efficiency is disaggregated into a series of variable-specific structural efficiencies. It reveals that fixed assets and non-interest incomes constitute the primary sources of structural inefficiency during the study period. Furthermore, the structural efficiencies of small-medium commercial banks surpass those of large state-owned commercial banks, although the efficiency gap between the two types of banks has narrowed. Based on the variable-specific structural efficiencies, this paper further explores the structural efficiency patterns within the Chinese banking sector.
Zitieren
APA
Yu, Z., Liu, Y., Ma, B., Baležentis, T., & Zhu, N. (2026). Potential structural efficiency of Chinese commercial banks. Journal of Business Economics and Management, 27(2), 243-261. https://doi.org/10.3846/jbem.2026.25750
Vancouver
Yu Z, Liu Y, Ma B, Baležentis T, Zhu N. Potential structural efficiency of Chinese commercial banks. Journal of Business Economics and Management. 2026;27(2):243-261. doi:10.3846/jbem.2026.25750
BibTeX
@article{Yu2026,
author = {Yu, Zhiqian and Liu, Yuning and Ma, Biyin and Baležentis, Tomas and Zhu, Ning},
title = {Potential structural efficiency of Chinese commercial banks},
journal = {Journal of Business Economics and Management},
year = {2026},
volume = {27},
number = {2},
pages = {243--261},
doi = {10.3846/jbem.2026.25750}
}
EUVIMED